JLL Partners with Solvias on continuation fund: the advisors
Lenz & Staehelin is advising both parties in connection with the continuation fund aimed at extending JLL Partners’ investment in Solvias. The operation originated through an older JLL Partners fund who acquired Solvias in 2020 alongside Water Street Healthcare Partners.
Moreover, Niederer Kraft Frey (NKF) is the Swiss legal advisor for the financing providers.
The parties
JLL Partners is a middle market private equity firm whose focus lays across the healthcare, specialty industrials, and business services sectors.
Headquartered in Switzerland, internationally active group Solvias specialises in contract pharmaceutical research, testing, as well as the manufacturing of pharmaceutical products. The company’s offering spans method development, release testing, biological analysis, custom synthesis and ligand catalyst technologies.
The Lenz & Staehelin team
Tax partner Floran Ponce (pictured above) leads the Lenz & Staehelin team on the matter, working alongside Maximilien de Ridder and Nicolas Demole (both tax), Roman Graf and Vera Waldburger (both corporate and M&A), David Ledermann, Marcel Tranchet, Manuela Scerri and Alex Coulaud (financing), Anja Affolter Marino, Julia van Heusden and Daniela Guggenbühl (employment).
The NKF team
Transaction partners Philip Spoerlé (pictured left) and Philippe Weber (pictured right) lead the NKF team, with further supports from associates Selim Lötscher and Benedikt Hadorn (both transactions), junior associate Géraldine Küderli (transactions), partner Markus Kronauer and senior associate Vanessa Witschi (both tax). A Cravath, Swaine & Moore LLP team cooperates with NKF, acting as US counsel.
